[ad_1]
Price COVID-19 vaccines BioNTech and Pfizer will be “below typical market rates” and will differ by country and region.
This was reported by The Guardian. It is indicated that the drug is intended to be used in two injections. Development companies have not yet received all the permits from regulatory bodies.
According to Pfizer and BioNTech, the cost of the vaccine will reflect the financial risks of its private sector investors.
“We have tried to take a balanced approach that recognizes that innovation requires capital and investment. We plan to price our vaccine well below typical market rates due to the situation we are in and ensure widespread access throughout the world”.– said the head of the strategic department of the German company BioNTech Ryan Richardson.
“I expect differentiated prices in some regions of the world.”He added, refusing to go into detail about the different costs.
As OBOZREVATEL reported:
